NextStage-backed Eurobio Scientific completed the acquisition of Genome Diagnostics for €135m.

NextStage-backed Eurobio Scientific, a French group operating in vitro medical diagnostics and life sciences industry, completed the acquisition of Genome Diagnostics, a provider of molecular diagnostics tools, for €135m ($137m). "This operation is transformative for Eurobio Scientific and is fully in line with the development strategy that we have been successfully pursuing for several years and which is based on a direct presence in Europe and an increase in the share of proprietary products. The strong complementarity between our two groups should make it possible to increase the advance of our Group both technologically, geographically and commercially," Denis Fortier, Eurobio Scientific Deputy Managing Director and Co-CEO.